Invention Grant
- Patent Title: Targeted therapeutic nanoparticles
-
Application No.: US14847213Application Date: 2015-09-08
-
Publication No.: US09694085B2Publication Date: 2017-07-04
- Inventor: Roy R. Yeoman , Richard A. Winchurch
- Applicant: nanoDERM Sciences, Inc.
- Applicant Address: US MD Derwood
- Assignee: nanoDERM Sciences, Inc.
- Current Assignee: nanoDERM Sciences, Inc.
- Current Assignee Address: US MD Derwood
- Agency: Pike IP Law, PLLC
- Agent Bernard G. Pike
- Main IPC: A61K47/48
- IPC: A61K47/48 ; A61K31/713 ; A61K39/44 ; A61K49/00 ; A61K38/12 ; A61K45/06 ; A61K9/06 ; A61K47/36 ; B82Y5/00 ; C08B37/02 ; C08J3/075 ; C08L5/02 ; C08L63/00 ; C08G65/332

Abstract:
Disclosure of methods and compositions related to chemical conjugations to nanoparticles of polysaccharides cross-linked to poloxamers as well as nano-sized colloids comprised of polysaccharides and poloxamers. The nanoparticles may be produced by various methods including inverse miniemulsion polymerization processes which create nanogels of desired size, shape, and stability for controlled therapeutic drug delivery, imaging, and theragnostic applications.
Public/Granted literature
- US20160106852A1 TARGETED THERAPEUTIC NANOPARTICLES Public/Granted day:2016-04-21
Information query